Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
India orders 14.5 mn more COVID-19 vaccine doses from SII and Bharat Biotech
It has ordered 10 million more doses from the Serum Institute of India and 4.5 million from Bharat Biotech
Lupin gets US FDA nod for Tavaborole Topical Solution
It is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or…
Vaccine trials essential to evaluate effectiveness against new COVID-19 variants: GlobalData
The largest proportion of the ongoing vaccine trials are now in Phase II (38.6 per cent) and Phase III (36.3 per cent), after…
Rhizen Pharma’s partnered asset Umbralisib gets US FDA accelerated nod for relapsed or…
Umbralisib is a novel, next generation, oral, once daily, inhibitor of phosphoinositide 3 kinase (PI3K) delta and casein kinase 1…
Bain Capital, Cinven to acquire Lonza Specialty Ingredients for $4.7 billion
Lonza is doubling down on its accelerating drug business
881 ongoing overcharging cases worth Rs 8184.19 cr under DPCO: D V Sadananda Gowda
324 cases, worth Rs 6550.37 crores, are under litigation in various courts
SMS Life Sciences India gets DSIR recognition for Hyderabad R&D unit
The said registration is valid upto March 31, 2023
Indian pharma market expected to grow to $130 bn by 2030: Gowda
India is being applauded globally in its fight against COVID, development of seven more vaccines is in pipeline: Mansukh Mandaviya
US FDA makes five observations after Alembic Pharma facility inspection
Alembic Pharma informed that “none of the observations are related to data integrity and are procedural in nature”
Clinical Data Standards in the era of AI, ML and digital transformation
Shrishaila Patil, VP, Statistical Programming, Navitas Data Sciences, a part of Navitas Life Sciences (a TAKE Solutions…